Gallmetzer HealthCare S.p.A.

€3.40As of Sun 8 Nov 2026, 12:00 UTC

VIE:GHCHealthcare

Country Austria

PE (Fwd) —

TSR 10Y CAGR —

Div yield —

ROE (7.00%)

Drug Manufacturers (Specialty & Generic)

Beta (5Y) —

PE TTM —

TSR TTM —

Mkt cap €54.40M

ROIC 0.33%

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

€3.80

11.79%

(91.39%)

Buy 0|1|0|0|0

TTM

FYE 31 Dec EUR

FY2025

FY2026E

Trend

10Y

Peers

59.23

Revenue€M

—

59.23

—

Revenue growth%

—

14.84

Gross margin%

—

14.84

—

0.09

Operating margin%

—

0.09

—

(0.94)

Net margin%

—

(0.94)

—

P/E ratio (avg)x

—

1,127

EV/EBITx

—

1,129

—

FCF yield (avg)%

—

(0.22)

—

(0.20)

FCF margin%

—

(0.20)

—

0.217

FCF / Net incomex

—

0.217

—

0.217

—

0.33

ROIC%

—

0.33

0.34

0.33

—

(7.00)

Return on equity%

—

(7.00)

(7.25)

(7.00)

—

(1.58)

Return on assets%

—

(1.58)

(1.61)

(1.58)

—

EPS€

—

(0.03)

—

EPS growth%

—

Bookvalue per sh€

—

0.46

—

FCF per share€

—

(0.01)

—

Dividend per sh€

—

Div yield (avg)%

—

Payout ratio%

—

16.00

Shares (diluted)M

—

◌16.00

—

Buyback yield%

—

1.144

D/E ratiox

—

1.144

1.230

1.144

—

63.36

Enterprise value€M

—

63.48

—

1.694

LT debt€M

—

1.694

1.696

—

Peers (US$61.08M)

Cap (US$)

PiùMedical S.p.A.

46.95M

—

Svas Biosana S.p.A.

46.92M

6.188x

I.M.D. International…

24.12M

17.11x

Cosmax Nbt, Inc.

60.85M

2.961x

Capital

TTM

10Y

Leveragex

8.551

EBIT/Intx

0.136

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

0.03

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

—

Revenue growth years

—

EPS growth years

—

Dividend streakyrs

—

Op margin range%

—

$1 testx

—

Incr. ROIC%

—

Gallmetzer HealthCare S.p.A. operates as an integrated dental and oral-care group in Italy. The company operates in the dental, pharmaceutical and healthcare sectors. The company mainly engages in the field of dental anesthesia and sustainable oral care. It develops and manufactures anesthetic solutions including Promis, a line of bio-certified, vegan oral care products.

Growth vs revenue

Latest

Trend

CAGR

Rel growth

Revenue

€59.23M

Cost of revenue

€50.45M

Operating expenses

€8.733M

Asset mix

Trend

Goodwill & intangibles

55.49%

Other

44.17%

Cash and investments

0.34%

Reinvestment returns

No breakdown available